Diabetes Care Devices – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific diabetes care device market was impacted by COVID-19 in 2020. Beyond the pandemic, moderate growth is anticipated over the forecast period, driven by favorable demographics and the adoption of advanced products—such as hybrid closed-loop insulin pumps—that command a premium price. However, the markets—particularly in China and India—continue to be limited by strong cost constraints that impede the uptake of premium-priced products.

This Medtech 360 Report provides high-level market metrics for diabetes care devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region from 2019 through 2031.